middle.news
Island Pharmaceuticals Advances Galidesivir with FDA Animal Rule Pathway and Biodefence Focus
9:46am on Thursday 11th of June, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Advances Galidesivir with FDA Animal Rule Pathway and Biodefence Focus
9:46am on Thursday 11th of June, 2026 AEST
Key Points
Expanded CRADA with USAMRIID secures non-human primate supply for dose optimisation
GMP manufacturing campaign underway to support pivotal Marburg virus studies
Galidesivir shows strong efficacy in non-human primate models against multiple filoviruses
FDA confirms Animal Rule pathway and Tropical Disease Priority Review Voucher eligibility
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE